ask="4.00"
ask_size="1000"
average_daily_volume="533872"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="-0.12"
change_from_200_day_moving_average="1.26"
change_from_50_day_moving_average="0.87"
change_from_52_week_high="-0.43"
change_From_52_week_low="2.30"
change_in_percent="-3.49%"
close="3.32"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.10"
ebitda="-24.72M"
eps_estimate_current_year="-1.13"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.94"
ex_dividend_date="N/A"
float_shares="20320000"
high="3.48"
high_52_weeks="3.75"
last_trade_date="3/7/2017"
last_trade_price="3.32"
last_trade_size="200"
last_trade_time="3:59pm"
low="3.23"
low_52_weeks="1.02"
market_capitalization="77.84M"
moving_average_200_day="2.06"
moving_average_50_day="2.45"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="5.67"
open="3.44"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+61.34%"
percent_change_from_50_day_moving_average="+35.57%"
percent_change_from_52_week_high="-11.47%"
percent_change_from_52_week_low="+225.49%"
previous_close="3.44"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.89"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="0.89"
stock_exchange="NCM"
symbol="CBAY"
volume="347946"
weeks_range_52="1.02 - 3.75"
